Difficulty: Medium
Average Score: 88%
Practice
A 21-year-old female presented to clinic for lesions on her vulva. The painful and itchy lesions have a red base and are vesicular. She recently has had a new sexual partner. The diagnosis of herpes is established and the patient is started on acyclovir. She becomes resistant to acyclovir and it therefore becomes ineffective. What is the mechanism of resistance for acyclovir?
Correct answer
A
Rationale
In this scenario, the correct answer is A) Lack of thymidine kinase. Acyclovir is an antiviral medication that requires activation by viral thymidine kinase in order to become effective against herpes viruses. Thymidine kinase is an enzyme present in herpes-infected cells that converts acyclovir into its active form. If the virus lacks thymidine kinase or has a mutated form of it, as in the case of drug-resistant strains, acyclovir cannot be activated and is therefore ineffective.
Option B) Lack of viral kinase is incorrect because it does not specifically address the role of thymidine kinase in acyclovir activation for herpes viruses.
Option C) Mutated CMV DNA polymerase is incorrect as it refers to cytomegalovirus (CMV) DNA polymerase, which is not directly related to the mechanism of resistance to acyclovir in herpes infections.
Option D) Mutation in DNA polymerase is also incorrect as it does not address the specific enzyme, thymidine kinase, that is crucial for activating acyclovir against herpes viruses.
From an educational perspective, understanding the mechanism of action and resistance of chemotherapy drugs, such as acyclovir, is vital for healthcare professionals to make informed decisions regarding treatment strategies and patient care. This case highlights the importance of recognizing how drug resistance can develop in viral infections and the specific role of enzymes like thymidine kinase in the efficacy of antiviral medications.
Option B) Lack of viral kinase is incorrect because it does not specifically address the role of thymidine kinase in acyclovir activation for herpes viruses.
Option C) Mutated CMV DNA polymerase is incorrect as it refers to cytomegalovirus (CMV) DNA polymerase, which is not directly related to the mechanism of resistance to acyclovir in herpes infections.
Option D) Mutation in DNA polymerase is also incorrect as it does not address the specific enzyme, thymidine kinase, that is crucial for activating acyclovir against herpes viruses.
From an educational perspective, understanding the mechanism of action and resistance of chemotherapy drugs, such as acyclovir, is vital for healthcare professionals to make informed decisions regarding treatment strategies and patient care. This case highlights the importance of recognizing how drug resistance can develop in viral infections and the specific role of enzymes like thymidine kinase in the efficacy of antiviral medications.